Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
American Federation of State et al v. Bristol-Myers Squibb Co. et al
Case Number:
1:12-cv-02238
Court:
Nature of Suit:
Racketeer/Corrupt Organization
Judge:
Firms
Companies
Sectors & Industries:
-
June 03, 2013
Bristol-Myers Copay Subsidies Not Bribes, Judge Finds
A federal judge said Monday that Bristol-Myers Squibb Co.'s practice of subsidizing patients' drug copays didn't constitute illegal bribery, dismissing a putative class action brought by insurers that complain the payments push patients to choose brand-name drugs over cheaper generics.
-
August 03, 2012
JPML Won't Centralize Drug Co-Pay Coupon Class Actions
The Judicial Panel for Multidistrict Litigation on Thursday declined to centralize in Illinois seven class actions accusing GlaxoSmithKline LLC, Pfizer Inc. and seven other major drugmakers of racketeering and antitrust violations for allegedly subsidizing illegal co-payments for brand-name prescription drugs.